The importance of determining the limit of detection of non-invasive prenatal testing methods

Prenatal Diagnosis

Volumn 36, Issue 4, 2016, Pages 304-311

  Fiorentino, Francesco ^a   Bono, Sara ^a   Pizzuti, Francesca ^a   Mariano, Martina ^a   Polverari, Arianna ^a   Duca, Sara ^a   Sessa, Mariateresa ^a   Baldi, Marina ^a   Diano, Laura ^a   Spinella, Francesca ^a  

^a GENOMA Group   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE DNA; DNA; UNCLASSIFIED DRUG;

ADULT; ANEUPLOIDY; ARTICLE; AUTOSOMAL DISORDER; BLOOD SAMPLING; CHROMOSOME; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA SEQUENCE; EXPERIMENTAL MODEL; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FETAL FRACTION; FETUS CELL; HIGH RISK PREGNANCY; HUMAN; INCIDENCE; KARYOTYPE; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MASSIVELY PARALLEL SEQUENCING; MATERNAL PLASMA; MATHEMATICAL MODEL; NON INVASIVE PROCEDURE; NONIVASIVE PRENATAL TESTING; NORMALIZED CHROMOSOME VALUE; PLASMA; PREDICTIVE VALUE; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRISOMY; BLOOD; CELL FREE SYSTEM; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME DISORDERS; DOWN SYNDROME; GENETIC SCREENING; HIGH THROUGHPUT SEQUENCING; MATERNAL SERUM SCREENING TEST; MIDDLE AGED; PREGNANCY; PROCEDURES; STANDARDS;

ADULT; ANEUPLOIDY; CELL-FREE SYSTEM; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DNA; DOWN SYNDROME; FEMALE; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIMIT OF DETECTION; MATERNAL SERUM SCREENING TESTS; MIDDLE AGED; PREGNANCY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TRISOMY;

EID: 84961799049     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4780     Document Type: Article

References (32)

1. Chitty LS, Bianchi DW. Noninvasive prenatal testing: the paradigm is shifting rapidly. Prenat Diagn 2013;33:511-3.
2. Gil MM, Quezada MS, Revello R, et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015;45:249-66.
3. Committee Opinion No. 640: cell-free DNA screening for fetal aneuploidy. Obstet Gynecol 2015;126:e31-7.
4. Society for Maternal-Fetal Medicine (SMFM). Publications committee #36: prenatal aneuploidy screening using cell-free DNA. Am J Obstet Gynecol 2015;212:711-6.
5. Benn P, Borrell A, Chiu RW, et al. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2015;35:725-34.
6. Dondorp W, deWert G, Bombard Y, et al. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Summary and recommendations. Eur J Hum Genet 2015;23:1592, DOI: 10.1038/ejhg.2015.56.
7. Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013;15:395-8.
8. Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 2008;105:16266-16271.
9. Chiu RW, Chan KC, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008;105:20458-20463.
10. Sehnert AJ, Rhees B, Comstock D, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011;57:1042-9.
11. Zimmermann B, Hill M, Gemelos G, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 2012;32:1233-1241.
12. Sparks AB, Wang ET, Struble CA, et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012;32:3-9.
13. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-20.
14. Norton ME, Brar H, Weiss J, et al. Non-invasive Chromosomal Evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.e1-8.
15. Wang E, Batey A, Struble C, et al. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn 2013;33:662-666.
16. Fan HC, Quake SR. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLoS One 2010;5:e10439.
17. Benn P, Cuckle H. Theoretical performance of non-invasive prenatal testing for chromosome imbalances using counting of cell-free DNA fragments in maternal plasma. Prenat Diagn 2014;34:778-83.
18. Canick JA, Palomaki GE, Kloza EM, et al. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn 2013;33:667-74.
19. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14:296-305.
20. Sparks AB, Struble CA, Wang ET, et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206:319.e1-319.e9.
21. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204:205.e1-11.
22. Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11, 105 pregnancies with mixed risk factors. Prenat Diagn 2012;32:1225-32.
23. Pergament E, Cuckle H, Zimmermann B, et al. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol 2014;124(2 Pt 1):210-8.
24. Dar P, Curnow KJ, Gross SJ, et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol 2014;211:527.e1-17.
25. Ashoor G, Poon L, Syngelaki A, et al. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: effect of maternal and fetal factors. Fetal Diagn Ther 2012;31:237-43.
26. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
27. Futch T, Spinosa J, Bhatt S, et al. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013;33:569-74.
28. Rava RP, Srinivasan A, Sehnert AJ, et al. Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. Clin Chem 2014;60:243-50.
29. McCullough RM, Almasri EA, Guan X, et al. Non-invasive prenatal chromosomal aneuploidy testing - clinical experience: 100, 000 clinical samples. PLoS One 2014;9:e109173.
30. Norton ME, Jacobsson B, Swamy GK, et al. Cell-free DNA analysis for non invasive examination of trisomy. N Engl J Med 2015;372:1589-97.
31. Kinnings SL, Geis JA, Almasri E, et al. Factors affecting levels of circulating cell-free fetal DNA in maternal plasma and their implications for non invasive prenatal testing. Prenat Diagn 2015;35:816-22.
32. Chitty LS. Use of cell-free DNA to screen for Down's syndrome. N Engl J Med 2015;372:1666-7.